These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunological aspects of psoriasis. IV. Presence of circulating immune complexes in patients before and after PUVA therapy; correlations with T-cell markers. Guilhou JJ; Clot J; Guillot B; Andary M; Meynadier J Br J Dermatol; 1980 Feb; 102(2):173-8. PubMed ID: 6966934 [TBL] [Abstract][Full Text] [Related]
3. Effect of PUVA treatment on the locomotion of polymorphonuclear leukocytes and mononuclear cells in psoriasis. Silny W; Pehamberger H; Zielinsky C; Gschnait F J Invest Dermatol; 1980 Aug; 75(2):187-8. PubMed ID: 6893337 [TBL] [Abstract][Full Text] [Related]
4. Scheduled DNA-synthesis after SUP and oral PUVA-treatment of psoriasis. Pullmann H; Galosi A; Zotos M; Steigleder GK Arch Dermatol Res; 1980; 268(1):105-7. PubMed ID: 6893393 [No Abstract] [Full Text] [Related]
5. Combined therapy with oral retinoid and PUVA baths in severe psoriasis. Michaëlsson G; Norén P; Vahlquist A Br J Dermatol; 1978 Aug; 99(2):221-2. PubMed ID: 698110 [No Abstract] [Full Text] [Related]
6. From the NIH: a look at the management of psoriasis. JAMA; 1980 Apr; 243(14):1429. PubMed ID: 7359713 [No Abstract] [Full Text] [Related]
8. [Does PUVA therapy affect the number of T-lymphocytes in patients with psoriasis vulgaris?]. Kaben U; Westphal HJ Dermatol Monatsschr; 1983; 169(10):663-8. PubMed ID: 6605886 [No Abstract] [Full Text] [Related]
9. Histological features of PUVA-induced bullae in psoriatic skin. McGibbon DH; Vella Briffa D Clin Exp Dermatol; 1978 Dec; 3(4):371-5. PubMed ID: 737881 [No Abstract] [Full Text] [Related]
10. [DNA-repair of lymphocytes during PUVA-treatment (author's transl)]. Bohnert E; Humbel WG Arch Dermatol Res; 1980; 267(2):175-8. PubMed ID: 6893264 [TBL] [Abstract][Full Text] [Related]
11. Histologic, immunofluorescent, and antinuclear antibody findings in PUVA-treated patients. Levin DL; Roenigk HH; Caro WA; Lyons M J Am Acad Dermatol; 1982 Mar; 6(3):328-33. PubMed ID: 7040505 [TBL] [Abstract][Full Text] [Related]
12. [Photochemotherapy (PUVA)]. de la Brassinne M; Cornet F Rev Med Liege; 1979 Jan; 34(2):55-60. PubMed ID: 419342 [No Abstract] [Full Text] [Related]
13. The active compounds derived from Psoralea corylifolia for photochemotherapy against psoriasis-like lesions: The relationship between structure and percutaneous absorption. Alalaiwe A; Hung CF; Leu YL; Tahara K; Chen HH; Hu KY; Fang JY Eur J Pharm Sci; 2018 Nov; 124():114-126. PubMed ID: 30153523 [TBL] [Abstract][Full Text] [Related]
15. T lymphocyte E rosette function during photochemotherapy (PUVA) of psoriasis. Haftek M; Gliński W; Jabłońska S; Obałek S J Invest Dermatol; 1979 May; 72(5):214-8. PubMed ID: 313426 [No Abstract] [Full Text] [Related]
16. [The effect of PUVA therapy on circulating T lymphocytes]. Mutevelić-Arslanagić N Med Arh; 1992; 46(1-2):23-4. PubMed ID: 1345548 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical studies on inflammatory infiltrates in psoriasis. Kaneko F; Kawagishi I; Miura Y; Watanabe M; Kishiyama K; Ohkawara A J Dermatol; 1984 Feb; 11(1):73-9. PubMed ID: 6376578 [No Abstract] [Full Text] [Related]
18. Bath psoralen+ultraviolet A photochemotherapy vs. narrow band-ultraviolet B in psoriasis: a comparison of clinical outcome and effect on circulating T-helper and T-suppressor/cytotoxic cells. Salem SA; Barakat MA; Morcos CM Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):235-42. PubMed ID: 20831697 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the relative therapeutic efficacy of 7-methyl pyridopsoralen and 8-methoxypsoralen in photochemotherapy in psoriasis treatment. Takashima A; Sunohara A; Mizuno N J Dermatol; 1988 Jun; 15(3):195-201. PubMed ID: 3053827 [No Abstract] [Full Text] [Related]